Tao Deng is the Associate Director of Immuno-Oncology Translational Medicine at AstraZeneca, where they utilize functional genomics and single-cell multi-omics technologies to discover novel biomarkers and cancer immunotherapy strategies. With over 15 years of interdisciplinary research experience, they previously served as a Staff Scientist at the National Center for Advancing Translational Sciences, focusing on disease modeling and therapeutic strategies. Tao completed a Ph.D. in Cell Biology at the Shanghai Institute of Biochemistry and Cell Biology after earning a B.S. in Life Science from East China University of Science and Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices